莱美药业：关于参加第十一批全国药品集中采购拟中选的公告

Core Viewpoint - The company, Laimei Pharmaceutical, announced its participation in the 11th batch of national drug centralized procurement organized by the National Drug Procurement Office, with its product Nicorandil tablets expected to be selected in this procurement process [2] Group 1 - Laimei Pharmaceutical participated in the 11th batch of national drug centralized procurement [2] - The National Drug Procurement Office published the proposed selection results for the centralized procurement [2] - Nicorandil tablets from the company are expected to be selected in this procurement [2]